DiLeo Morgan V, Fisher James D, Federspiel William J
McGowan Institute for Regenerative Medicine, University of Pittsburgh, 215 McGowan Institute, 3025 East Carson Street, Pittsburgh, PA 15203, USA.
Ann Biomed Eng. 2009 Nov;37(11):2310-6. doi: 10.1007/s10439-009-9780-4. Epub 2009 Aug 14.
Sepsis, a systemic inflammatory response in the presence of an infection, is characterized by overproduction of inflammatory mediators called cytokines. Removal of these cytokines using an extracorporeal hemoadsorption device is a potential therapy for sepsis. We are developing a cytokine adsorption device (CAD) filled with microporous polymer beads and have previously published a mathematical model which predicts the time course of cytokine removal by the device. The goal of this study was to show that the model can experimentally predict the rate of cytokine capture associated with key design and operational parameters of the CAD. We spiked IL-6, IL-10, and TNF into horse serum and perfused it through an appropriately scaled-down CAD and measured the change in concentration of the cytokines over time. These data were fit to the mathematical model to determine a single model parameter, Gamma( i ), which is only a function of the cytokine-polymer interaction and the cytokine effective diffusion coefficient in the porous matrix. We compared Gamma( i ) values, which by definition should not change between experiments. Our results indicate that the Gamma( i ) value for a specific cytokine was statistically independent of all other parameters in the model, including initial cytokine concentration, flow rate, serum reservoir volume, CAD size, and bead size. Our results also indicate that competitive adsorption of cytokines and other middle-molecular weight proteins, which is neglected in the model, does not affect the rate of removal of a given cytokine. The model of cytokine capture in the CAD developed in this study will be integrated with a systems model of sepsis to simulate the progression of sepsis in humans and to develop a therapeutic CAD design and intervention protocol that improves patient outcomes in sepsis.
脓毒症是一种在感染存在时发生的全身性炎症反应,其特征是称为细胞因子的炎症介质过度产生。使用体外血液吸附装置去除这些细胞因子是脓毒症的一种潜在治疗方法。我们正在开发一种填充有微孔聚合物珠的细胞因子吸附装置(CAD),并且此前已经发表了一个数学模型,该模型可预测该装置去除细胞因子的时间进程。本研究的目的是表明该模型能够通过实验预测与CAD的关键设计和操作参数相关的细胞因子捕获率。我们将白细胞介素-6(IL-6)、白细胞介素-10(IL-10)和肿瘤坏死因子(TNF)加入马血清中,并通过适当缩小比例的CAD进行灌注,同时测量细胞因子浓度随时间的变化。将这些数据与数学模型进行拟合,以确定单个模型参数Gamma(i),它仅是细胞因子与聚合物相互作用以及细胞因子在多孔基质中的有效扩散系数的函数。我们比较了Gamma(i)值,根据定义,这些值在不同实验之间不应发生变化。我们的结果表明,特定细胞因子的Gamma(i)值在统计学上独立于模型中的所有其他参数,包括初始细胞因子浓度、流速、血清储液器体积、CAD尺寸和珠粒尺寸。我们的结果还表明,模型中未考虑的细胞因子与其他中分子量蛋白质的竞争性吸附不会影响给定细胞因子的去除率。本研究中开发的CAD中细胞因子捕获模型将与脓毒症系统模型相结合,以模拟人类脓毒症的进展,并制定治疗性CAD设计和干预方案,以改善脓毒症患者的预后。